MAPT and amyloidosis: Specifically, the combination of multiple markers of synaptic changes and primary AD pathophysiology (i.e., Aβ and tau) will be critical in determining a more mechanistic disease model and help identify whether and how amyloid-associated pre- or post-synaptic changes contribute to tau spreading and how tau induces synaptic degeneration47.